AAPL316.22+2.83 (+0.90%) ▲|ABBV249.91-2.83 (-1.12%) ▼|ABT94.40-0.78 (-0.82%) ▼|ACN139.06+3.50 (+2.58%) ▲|ADBE222.65+1.71 (+0.77%) ▲|AMAT588.66+18.16 (+3.18%) ▲|AMD546.72+29.32 (+5.67%) ▲|AMGN363.62-4.37 (-1.19%) ▼|AMT165.00-0.04 (-0.02%) ▼|AMZN247.04+3.42 (+1.40%) ▲|AVGO401.11+12.42 (+3.20%) ▲|AXP346.72+10.33 (+3.07%) ▲|BA223.11-1.84 (-0.82%) ▼|BAC59.25+0.95 (+1.63%) ▲|BKNG175.52+1.23 (+0.71%) ▲|BLK1,019.68+29.34 (+2.96%) ▲|BMY57.94+0.40 (+0.70%) ▲|BNY152.26+2.12 (+1.41%) ▲|BRK-B495.45+0.66 (+0.13%) ▲|C139.57+2.18 (+1.59%) ▲|CAT938.39-9.69 (-1.02%) ▼|CL91.01-2.03 (-2.18%) ▼|CMCSA23.35+0.16 (+0.67%) ▲|COF200.10+8.15 (+4.25%) ▲|COP108.02-2.70 (-2.44%) ▼|COST912.97-40.16 (-4.21%) ▼|CRM162.50-4.08 (-2.45%) ▼|CSCO118.31+4.49 (+3.94%) ▲|CVS102.81-1.66 (-1.59%) ▼|CVX174.05-1.92 (-1.09%) ▼|DE592.90-3.84 (-0.64%) ▼|DHR195.98+5.21 (+2.73%) ▲|DIS96.17-0.53 (-0.55%) ▼|DUK125.26-1.53 (-1.21%) ▼|EMR137.80+1.32 (+0.97%) ▲|FDX310.84+1.08 (+0.35%) ▲|GD374.60+0.29 (+0.08%) ▲|GE359.04+3.01 (+0.85%) ▲|GEV1,075.26+4.27 (+0.40%) ▲|GILD134.84-0.98 (-0.72%) ▼|GM76.65+0.41 (+0.54%) ▲|GOOG356.24-2.47 (-0.69%) ▼|GOOGL358.89-3.03 (-0.84%) ▼|GS1,055.97+26.33 (+2.56%) ▲|HD338.73+2.52 (+0.75%) ▲|HON223.42+3.06 (+1.39%) ▲|IBM295.30-6.75 (-2.23%) ▼|INTC112.54+2.30 (+2.09%) ▲|INTU273.38+1.28 (+0.47%) ▲|ISRG411.55-3.55 (-0.86%) ▼|JNJ259.10-4.30 (-1.63%) ▼|JPM335.47+4.85 (+1.47%) ▲|KO82.63-0.77 (-0.92%) ▼|LIN525.56-2.11 (-0.40%) ▼|LLY1,216.95+1.12 (+0.09%) ▲|LMT518.26-9.70 (-1.84%) ▼|LOW213.00+0.15 (+0.07%) ▲|LRCX353.17+20.02 (+6.01%) ▲|MA523.20+4.21 (+0.81%) ▲|MCD276.49-1.76 (-0.63%) ▼|MDLZ58.30-1.18 (-1.98%) ▼|MDT82.39+0.38 (+0.46%) ▲|META631.48+28.36 (+4.70%) ▲|MMM155.34+0.64 (+0.41%) ▲|MO71.59-1.22 (-1.68%) ▼|MRK125.07-0.92 (-0.73%) ▼|MS222.13+4.06 (+1.86%) ▲|MSFT384.36+1.02 (+0.27%) ▲|MU991.64+42.84 (+4.52%) ▲|NEE87.10-0.34 (-0.39%) ▼|NFLX75.47-0.12 (-0.16%) ▼|NKE42.78-0.11 (-0.26%) ▼|NOW108.84+1.06 (+0.98%) ▲|NVDA202.78-1.34 (-0.66%) ▼|ORCL144.22+3.73 (+2.66%) ▲|PEP137.86-4.64 (-3.25%) ▼|PFE24.25+0.20 (+0.83%) ▲|PG146.85-1.55 (-1.04%) ▼|PLTR129.04-3.18 (-2.41%) ▼|PM181.17-5.90 (-3.15%) ▼|QCOM191.11+4.55 (+2.44%) ▲|RTX195.20+0.29 (+0.15%) ▲|SBUX106.41+2.54 (+2.45%) ▲|SCHW101.91+0.21 (+0.21%) ▲|SO95.17-1.21 (-1.26%) ▼|SPG219.71+0.62 (+0.28%) ▲|T21.04-0.08 (-0.38%) ▼|TMO524.71+14.58 (+2.86%) ▲|TMUS181.48+1.34 (+0.74%) ▲|TSLA406.55+12.62 (+3.20%) ▲|TXN308.53+7.21 (+2.39%) ▲|UBER74.35+0.75 (+1.02%) ▲|UNH431.68+6.08 (+1.43%) ▲|UNP285.04+4.10 (+1.46%) ▲|UPS110.74+0.80 (+0.73%) ▲|USB61.90+0.90 (+1.48%) ▲|V348.20+0.67 (+0.19%) ▲|VZ42.24-0.21 (-0.49%) ▼|WFC86.91+1.35 (+1.58%) ▲|WMT112.21-0.89 (-0.79%) ▼|XOM137.46-3.67 (-2.60%) ▼|AAPL316.22+2.83 (+0.90%) ▲|ABBV249.91-2.83 (-1.12%) ▼|ABT94.40-0.78 (-0.82%) ▼|ACN139.06+3.50 (+2.58%) ▲|ADBE222.65+1.71 (+0.77%) ▲|AMAT588.66+18.16 (+3.18%) ▲|AMD546.72+29.32 (+5.67%) ▲|AMGN363.62-4.37 (-1.19%) ▼|AMT165.00-0.04 (-0.02%) ▼|AMZN247.04+3.42 (+1.40%) ▲|AVGO401.11+12.42 (+3.20%) ▲|AXP346.72+10.33 (+3.07%) ▲|BA223.11-1.84 (-0.82%) ▼|BAC59.25+0.95 (+1.63%) ▲|BKNG175.52+1.23 (+0.71%) ▲|BLK1,019.68+29.34 (+2.96%) ▲|BMY57.94+0.40 (+0.70%) ▲|BNY152.26+2.12 (+1.41%) ▲|BRK-B495.45+0.66 (+0.13%) ▲|C139.57+2.18 (+1.59%) ▲|CAT938.39-9.69 (-1.02%) ▼|CL91.01-2.03 (-2.18%) ▼|CMCSA23.35+0.16 (+0.67%) ▲|COF200.10+8.15 (+4.25%) ▲|COP108.02-2.70 (-2.44%) ▼|COST912.97-40.16 (-4.21%) ▼|CRM162.50-4.08 (-2.45%) ▼|CSCO118.31+4.49 (+3.94%) ▲|CVS102.81-1.66 (-1.59%) ▼|CVX174.05-1.92 (-1.09%) ▼|DE592.90-3.84 (-0.64%) ▼|DHR195.98+5.21 (+2.73%) ▲|DIS96.17-0.53 (-0.55%) ▼|DUK125.26-1.53 (-1.21%) ▼|EMR137.80+1.32 (+0.97%) ▲|FDX310.84+1.08 (+0.35%) ▲|GD374.60+0.29 (+0.08%) ▲|GE359.04+3.01 (+0.85%) ▲|GEV1,075.26+4.27 (+0.40%) ▲|GILD134.84-0.98 (-0.72%) ▼|GM76.65+0.41 (+0.54%) ▲|GOOG356.24-2.47 (-0.69%) ▼|GOOGL358.89-3.03 (-0.84%) ▼|GS1,055.97+26.33 (+2.56%) ▲|HD338.73+2.52 (+0.75%) ▲|HON223.42+3.06 (+1.39%) ▲|IBM295.30-6.75 (-2.23%) ▼|INTC112.54+2.30 (+2.09%) ▲|INTU273.38+1.28 (+0.47%) ▲|ISRG411.55-3.55 (-0.86%) ▼|JNJ259.10-4.30 (-1.63%) ▼|JPM335.47+4.85 (+1.47%) ▲|KO82.63-0.77 (-0.92%) ▼|LIN525.56-2.11 (-0.40%) ▼|LLY1,216.95+1.12 (+0.09%) ▲|LMT518.26-9.70 (-1.84%) ▼|LOW213.00+0.15 (+0.07%) ▲|LRCX353.17+20.02 (+6.01%) ▲|MA523.20+4.21 (+0.81%) ▲|MCD276.49-1.76 (-0.63%) ▼|MDLZ58.30-1.18 (-1.98%) ▼|MDT82.39+0.38 (+0.46%) ▲|META631.48+28.36 (+4.70%) ▲|MMM155.34+0.64 (+0.41%) ▲|MO71.59-1.22 (-1.68%) ▼|MRK125.07-0.92 (-0.73%) ▼|MS222.13+4.06 (+1.86%) ▲|MSFT384.36+1.02 (+0.27%) ▲|MU991.64+42.84 (+4.52%) ▲|NEE87.10-0.34 (-0.39%) ▼|NFLX75.47-0.12 (-0.16%) ▼|NKE42.78-0.11 (-0.26%) ▼|NOW108.84+1.06 (+0.98%) ▲|NVDA202.78-1.34 (-0.66%) ▼|ORCL144.22+3.73 (+2.66%) ▲|PEP137.86-4.64 (-3.25%) ▼|PFE24.25+0.20 (+0.83%) ▲|PG146.85-1.55 (-1.04%) ▼|PLTR129.04-3.18 (-2.41%) ▼|PM181.17-5.90 (-3.15%) ▼|QCOM191.11+4.55 (+2.44%) ▲|RTX195.20+0.29 (+0.15%) ▲|SBUX106.41+2.54 (+2.45%) ▲|SCHW101.91+0.21 (+0.21%) ▲|SO95.17-1.21 (-1.26%) ▼|SPG219.71+0.62 (+0.28%) ▲|T21.04-0.08 (-0.38%) ▼|TMO524.71+14.58 (+2.86%) ▲|TMUS181.48+1.34 (+0.74%) ▲|TSLA406.55+12.62 (+3.20%) ▲|TXN308.53+7.21 (+2.39%) ▲|UBER74.35+0.75 (+1.02%) ▲|UNH431.68+6.08 (+1.43%) ▲|UNP285.04+4.10 (+1.46%) ▲|UPS110.74+0.80 (+0.73%) ▲|USB61.90+0.90 (+1.48%) ▲|V348.20+0.67 (+0.19%) ▲|VZ42.24-0.21 (-0.49%) ▼|WFC86.91+1.35 (+1.58%) ▲|WMT112.21-0.89 (-0.79%) ▼|XOM137.46-3.67 (-2.60%) ▼|
24.1 C
New York
Friday, July 10, 2026

Tag: access

newssourceFORcompanyinformationcontent1releasesmarket

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)

REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced positive topline results from a confirmatory efficacy study comparing AVT23 (ADL-018), a proposed biosimilar to Xolair® (omalizumab), with the reference biologic.

inCruises Breakthrough Year Continues with Record-Setting Revenue and Activations

Bold Partner-led strategies continue to build momentum and produce all-time highs in Activation and Premium Memberships revenue 
Bold Partner-led strategies continue to build momentum and produce all-time highs in Activation and Premium Memberships revenue

£7.5 million Longitude Prize on ALS launches

LONDON, June 25, 2025 /CNW/ -- The Longitude Prize on ALS, a £7.5 million global challenge prize, has launched to incentivise and reward cutting...

LexisNexis Risk Solutions and Kia Europe Enhance Driving Insights in the Kia App to Help Owners Reduce Risk and Seek Personalised Insurance Offerings

LONDON, June 25, 2025 /PRNewswire/ -- LexisNexis® Risk Solutions and Kia Connect have announced a strategic collaboration to enhance Kia's connected vehicle ecosystem. Kia Connect will...

Transaction in Own Shares

LEI: 213800NNT42FFIZB1T09 
25 June 2025

BRI Becomes First in Indonesia to Issue IDR 5 Trillion Social Bond to Support Inclusive, Sustainable Financing

JAKARTA, Indonesia, June 25, 2025 /PRNewswire/ -- PT Bank Rakyat Indonesia (Persero) Tbk, (IDX: BBRI) has officially issued its first Sustainable Social Bond Phase I...

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company’s multiomics strategy

Combines highly complementary proteomics expertise with Illumina's industry-leading product innovation and global market reach Positions Illumina to achieve growth in a large, expanding market Illumina and...

iValue Group Partners with Supermicro to Fuel Strategic Market Reach Across Key Regions

This partnership marks a pivotal step for both organizations, focusing on mutual growth and increased market footprint. BENGALURU, India, June 25, 2025 /PRNewswire/ -- iValue...

Verizon Business wins multisite private 5G contract fueling a multibillion dollar regeneration project

What you need to know:

SkyCrest Capital Launches Pension Plan with Ambitious 150% First-Week Target, Powered by LEXO Platform

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- SkyCrest Capital, a global fintech innovator, today announced the launch of its transformative Pension Plan, a structured asset growth initiative set to begin on Monday, June 23, 2025. Powered by the proprietary SAX-iCore AI Structural Recognition System and executed via the LEXO decentralized trading platform, the plan targets a 150% net return in its first week, offering individual traders and investors a disciplined, AI-driven path to wealth accumulation.

Moomoo Singapore Investor Sentiment Survey: Singapore Stocks Shine as Beacon of Confidence

SINGAPORE, June 24, 2025 /CNW/ -- Singapore stocks remain the strategic foundation of retail portfolios, data from Moomoo Singapore's 2H2025 Retail Investor Sentiment Survey...

GoNetZero™ and AlliedOffsets Partner to Help Businesses Navigate the Voluntary Carbon Market with Confidence

SINGAPORE and LONDON, June 25, 2025 /PRNewswire/ -- GoNetZero™, a global decarbonisation enabler in clean energy procurement and carbon management, announces a new strategic alliance...

Invest in Brookfield Renewable: Empower Your Financial Future Today!

Hey there, fabulous finance queens! 💁‍♀️ Ready to dive into a world where your money doesn't just sit pretty but works hard for you?...

BloodVitals Pain-Free Blood Glucose Monitoring Device Launches to Support At-Home Wellness Tracking

Innovative needle-free technology empowers users to monitor glucose signals, oxygen saturation, and heart rate from home—without the discomfort or complexity of traditional tools. 
Innovative needle-free technology empowers users to monitor glucose signals, oxygen saturation, and heart rate from home—without the discomfort or complexity of traditional tools.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAccess

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers